Companies › AQST

AQUESTIVE THERAPEUTICS INC (AQST)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001398733 · EDGAR filings · Updated 2026-07-27

AQUESTIVE THERAPEUTICS INC (AQST) has reported institutional ownership of 58.8%, with 178 institutional managers holding positions valued at $298.0M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-15 — Notice of proposed sale filed (Form 144)
• 2026-07-09 — Prospectus supplement (424B3) filed
• 2026-07-08 — EFFECT filed
• 2026-06-26 — Shelf registration (S-3) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, AQUESTIVE THERAPEUTICS INC has 178 institutional holders and institutional ownership of 58.8%.

Insider activity

Insiders reported 34 transactions (0 buys, 15 sells) across 12 reporting insiders, with a net reported value of −$3.34M.

Data flags from SEC filings

Related companies

LUMEXA IMAGING HOLDINGS INC (LMRI) · LENZ THERAPEUTICS INC (LENZ) · KYVERNA THERAPEUTICS INC (KYTX) · INVIVYD INC (IVVD) · FULGENT GENETICS INC (FLGT) · CERUS CORP (CERS)